STOCK TITAN

BioCryst to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) will be presenting at various upcoming investor conferences in May and June 2024. The presentations will take place in New York and Las Vegas, offering investors insights into the company's latest developments and future prospects.

Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following conferences:

  • Citizens JMP Life Sciences Conference in New York on Monday, May 13, 2024, at 12:30 p.m. ET.
  • 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024, at 3:05 p.m. ET.
  • Bank of America Health Care Conference 2024 in Las Vegas on Wednesday, May 15, 2024, at 5:20 p.m. ET.
  • H.C. Wainwright 2nd Annual BioConnect Investor Conference in New York on Monday, May 20, 2024, at 10:30 a.m. ET.
  • Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2024, at 9:30 a.m. ET.

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com


FAQ

When will BioCryst Pharmaceuticals, Inc. (BCRX) present at the Citizens JMP Life Sciences Conference?

BioCryst Pharmaceuticals, Inc. (BCRX) will present at the Citizens JMP Life Sciences Conference in New York on Monday, May 13, 2024, at 12:30 p.m. ET.

Where can I access the live audio webcasts and replays of BioCryst's presentations?

The live audio webcasts and replays of BioCryst's presentations can be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

What is the date and time of BioCryst's presentation at the Jefferies Global Healthcare Conference?

BioCryst will present at the Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2024, at 9:30 a.m. ET.

BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

BCRX Rankings

BCRX Latest News

BCRX Stock Data

1.32B
191.23M
1.16%
89.95%
16.65%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
DURHAM